Latest filing published 04 Dec 2007 for Altus Pharmaceuticals Inc., €1,336.
No signal scores available.
All filings by Robert Gallotto on record concern Altus Pharmaceuticals Inc. Over a trading history stretching from 1 November 2006 to 3 December 2007, the count stands at 28 filings.
On the market, this insider has only sold: 14 sales, €560k in total. Outside the open market, there are 14 option exercises. In 2007 alone, the filings show no purchases and 11 sales.
The newest entry dates from 4 December 2007: an open-market sale of €3,589, in Altus Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 26 declarations